Encephalomyelitis News and Research

RSS

Important development in the treatment of multiple sclerosis

A major step forward, with important implications for understanding how to reduce the severity of multiple sclerosis, has been made by scientists at the University of Bristol. The results are published online today in PNAS.

26 Aug 2009

Lyme disease emerging in Canada

Lyme disease is emerging in Canada, and is expected to increase with climate change, but effective, enhanced surveillance and clinician awareness will be key to minimizing the impact of the disease, write researchers in a review in CMAJ (Canadian Medical Association Journal).

9 Jun 2009

Studies on imaging and tracking transplanted cells

Successfully monitoring the distribution and fate of transplanted stem cells through imaging and subsequent tracking would aid clinicians in their ability to evaluate the efficacy of transplanted cells.

10 Dec 2008

Vaccine-related chronic fatigue syndrome in an individual demonstrating aluminium overload

A team of scientists have investigated a case of vaccine-associated chronic fatigue syndrome (CFS) and macrophagic myofasciitis in an individual demonstrating aluminium overload.

18 Nov 2008

Myalgic encephalomyelitis sufferers rely on aternative medicines

More than a third of patients with long-term fatigue conditions like Myalgic Encephalomyelitis (ME) believe complementary and alternative medicines (CAMs) are more effective than traditional medicine in treating their illness, research launched at the British Pharmaceutical Conference (BPC) in Manchester reveals.

7 Sep 2008

Caffeine could help prevent multiple sclerosis

A new study is suggesting that having several cups of coffee a day could halt the development of multiple sclerosis (MS).

2 Jul 2008

Researchers highlight distinct subtypes of myalgic encephalomyelitis

Researchers have identified distinct subtypes of myalgic encephalomyelitis (ME/CFS - also referred to as chronic fatigue syndrome) and there is renewed hope that treatments are available for this debilitating neurological illness.

7 May 2008

Caffeine prevents multiple sclerosis-like disease in mice

Mice given caffeine equivalent to a human drinking six to eight cups of coffee a day were protected from developing experimental autoimmune encephalomyelitis (EAE), the animal model for the human disease Multiple Sclerosis (MS), according to researchers at Cornell University.

8 Apr 2008

Brain molecule from endothelial cells may be a new target for treatment of multiple sclerosis

In the February issue of Nature Immunology, the team provides fresh answers concerning the role of novel adhesion molecules in the pathogenesis of MS, a chronic autoimmune disease of the nervous system that affects approximately 55,000 young adults in Canada.

23 Jan 2008

Anti-inflammation molecule helps fight MS-like disease

An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.

13 Nov 2007

FDA approves Acambis smallpox vaccine

Acambis plc (Acambis) has announced that the US Food and Drug Administration (FDA) has approved its ACAM2000 (Smallpox (Vaccinia) Vaccine, Live) vaccine for protection against smallpox.

4 Sep 2007

Academic comments on horse flu scare

We should not be shocked that equine influenza has emerged in Australia. What is surprising is that we kept it out for so long. The Australian thoroughbred breeding and racing industry has received huge financial benefits from globalisation, but this process carries enormous risks. Foremost is the risk of disease.

28 Aug 2007

Researchers clarify alphaB-crystallin's role in multiple sclerosis

A protein found primarily in the lens of the eye could be the critical "tipping point" in the spiral of inflammation and damage that occurs in multiple sclerosis, researchers at the Stanford University School of Medicine report.

18 Jun 2007

Modified bone marrow cells help recovery in an animal model of multiple sclerosis

These findings will need to be repeated in further animal models before the implications for human disease are clear; however, they open up an avenue of further research.

10 Apr 2007

Researchers show blood-brain barrier damage could affect multiple sclerosis severity

Immunology researchers at the Kimmel Cancer Center at Jefferson studying a multiple sclerosis (MS)-like disease in mice have shown that the amount of "damage" to the central nervous system's protective blood-brain barrier, in essence, opening it, almost always correlates to the severity of the disease.

7 Apr 2007

Chronic fatigue syndrome a public health epidemic says CDC

The Centers for Disease Control and Prevention (CDC) in the United States says more than a million Americans suffer from Chronic fatigue syndrome (CFS).

6 Nov 2006

Valganciclovir may be the drug for chronic fatigue syndrome

A drug used to treat herpes has produced dramatic results in people with chronic fatigue syndrome, reported the Daily Mail (16 May 2006).

17 May 2006

Hidden thousands devastated by myalgic encephalomyelitis

New research published by the UK's leading Myalgic Encephalomyelitis (M.E.) charity, Action for M.E., suggests that a hidden 55,000 people in Britain are so severely affected by the illness that they're either bed-bound or house-bound.

11 May 2006

Genetic clue found to Chronic Fatigue Syndrome

According to researchers from the Centers for Disease Control and Prevention (CDC), in the United States, there may well be a genetic reason why some people develop Chronic Fatigue Syndrome (CFS).

24 Apr 2006

Atorvastatin could prove an effective therapy for multiple sclerosis

Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that the cholesterol-lowering drug atorvastatin could prove an effective therapy for preventing the progression of, and reversing the severity of, multiple sclerosis (MS).

20 Mar 2006